High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT.
Saved in:
| Title: | High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. |
|---|---|
| Authors: | Chen, Hsin-Pao1,2 (AUTHOR), Chen, Chih-I1,2,3,4,5 (AUTHOR), Liu, Kuang-Wen1,2 (AUTHOR), Chen, Tzu-Ju6,7,8 (AUTHOR), Tian, Yu-Feng9 (AUTHOR), Kuo, Yu-Hsuan10,11 (AUTHOR), Li, Wan-Shan7,8,12 (AUTHOR), Tsai, Hsin-Hwa13,14 (AUTHOR), Wu, Li-Ching8,14 (AUTHOR), Yeh, Cheng-Fa15,16 (AUTHOR), Li, Chien-Feng13,14,17 (AUTHOR), Chou, Chia-Lin1,7,9 (AUTHOR) 991101@mail.chimei.org.tw, Lai, Hong-Yue1,13,14,18 (AUTHOR) hylai@mail.cmu.edu.tw |
| Source: | Pathology - Research & Practice. Nov2022, Vol. 239, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03440338 |
|---|---|
| DOI: | 10.1016/j.prp.2022.154158 |
